Zopiclone (Zopiclone)



Indications and Reactions:

Role Indications Reactions
Primary
Product Used For Unknown Indication 39.3%
Drug Use For Unknown Indication 29.5%
Sleep Disorder 13.1%
Depression 6.6%
Generalised Anxiety Disorder 6.6%
Cancer Pain 1.6%
Pain In Extremity 1.6%
Schizophrenia 1.6%
Psychotic Disorder 18.2%
Vomiting 18.2%
Hyperhidrosis 9.1%
Lower Respiratory Tract Infection 9.1%
Macrocytosis 9.1%
Pulmonary Oedema 9.1%
Single Functional Kidney 9.1%
Suicidal Behaviour 9.1%
Ventricular Fibrillation 9.1%
Secondary
Product Used For Unknown Indication 32.8%
Drug Use For Unknown Indication 30.8%
Depression 5.1%
Ill-defined Disorder 4.5%
Insomnia 3.6%
Intentional Overdose 3.6%
Schizophrenia 3.4%
Anxiety 3.0%
Sleep Disorder 2.4%
Staphylococcal Infection 2.0%
Colorectal Cancer Metastatic 1.6%
Abnormal Behaviour 1.2%
Emotional Distress 1.2%
Major Depression 0.8%
Toxicity To Various Agents 0.8%
Atrial Fibrillation 0.6%
Bronchiectasis 0.6%
Generalised Anxiety Disorder 0.6%
Hypotension 0.6%
Urinary Tract Infection 0.6%
Suicide Attempt 12.1%
Ventricular Fibrillation 9.9%
Confusional State 7.7%
Hypertension 7.7%
Multiple Drug Overdose Intentional 6.6%
Drug Interaction 5.5%
Toxicity To Various Agents 5.5%
Lower Respiratory Tract Infection 4.4%
Multiple Drug Overdose 4.4%
Overdose 4.4%
Priapism 4.4%
Suicidal Ideation 4.4%
Electrocardiogram Qt Prolonged 3.3%
Loss Of Consciousness 3.3%
Paranoia 3.3%
Rhabdomyolysis 3.3%
Withdrawal Syndrome 3.3%
Balance Disorder 2.2%
Drug Ineffective 2.2%
Hyponatraemia 2.2%
Concomitant
Product Used For Unknown Indication 20.5%
Depression 19.4%
Drug Use For Unknown Indication 10.6%
Pneumonia 6.5%
Schizophrenia 5.8%
Multiple Myeloma 5.4%
Anxiety 4.6%
Ill-defined Disorder 4.0%
Hypertension 3.6%
Renal Cell Carcinoma Stage Unspecified 2.7%
Non-small Cell Lung Cancer 2.3%
Pruritus 2.3%
Bipolar Disorder 1.7%
Colorectal Cancer Metastatic 1.7%
Pain 1.7%
Hepatitis C 1.5%
Urinary Tract Infection 1.5%
Deep Vein Thrombosis 1.3%
Lower Respiratory Tract Infection 1.3%
Major Depression 1.3%
Vomiting 11.3%
Completed Suicide 10.1%
Tremor 7.1%
Suicidal Ideation 6.5%
White Blood Cell Count Decreased 6.0%
Thrombocytopenia 4.8%
Weight Decreased 4.8%
Hyperhidrosis 4.2%
Renal Failure Acute 4.2%
Somnolence 4.2%
Syncope 4.2%
Vertigo 4.2%
Weight Increased 4.2%
Withdrawal Syndrome 4.2%
Rash 3.6%
Sudden Death 3.6%
Treatment Noncompliance 3.6%
Urinary Tract Infection 3.6%
Drug Interaction 3.0%
Paraesthesia 3.0%